Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate vs propofol for painless gastrointestinal endoscopy
ChiCTR2100042441Phase 4Recruiting
- Sponsor
- Rizhao Central Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in gastrointestinal conditions (2 arms), sponsored by Rizhao Central Hospital. Primary endpoint: Hemodynamics. Started Feb 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100042441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042441.